Postprandial lipaemia, metabolic syndrome and LDL particle size in urbanised South African blacks with and without coronary artery disease

QJM: An International Journal of Medicine

Volumn 101, Issue 2, 2008, Pages 111-119

  Ntyintyane, L M ^a   Panz, V R ^a   Raal, Frederick J ^a   Gill, G V ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; AREA UNDER THE CURVE; ARTICLE; BIOCHEMISTRY; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; METABOLIC SYNDROME X; NEGRO; PARTICLE SIZE; POSTPRANDIAL STATE; PRIORITY JOURNAL; SOUTH AFRICA; URBAN AREA;

EID: 39049096859     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcm137     Document Type: Article

References (47)

1. Gofman JW, Lindgren F The role of lipids and lipoproteins in atherosclerosis. Science 1950; 111:166-71.
2. Fraser R. The role of dietary triglycerides in cholesterol metabolism. Atherosclerosis, 1974; 19:327-36.
3. Zilversmit DB. Atherogenesis: A postprandial phenomenon. Circulation 1979; 60:473-85.
4. Kolovou GD, Anagnostopoulou KK, Daskalopoulou SS, Mikhailidis DP, Cokkinos DV. Clinical relevance of postprandial lipaemia. Curr Med Chem 2005; 12:763-71.
5. Brewer HB, Gregg RE, Hoeg JM, Fojo SS. Apolipoproteins and lipoproteins in human plasma: An overview. Clin Chem 1988; 34:B4-B8.
6. National Cholesterol Education Program (NCEP) Expert panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the NCEP Adult, Treatment Panel III. Circulation 2002; 106:3143-421.
7. Packard CJ. Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease. Curr Opin Lipidol 2006; 17:412-17.
8. Bernies KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Research 2002; 43:1363-79.
9. Patsch JR, Miesenböck G, Hopferwieser T, Mühlberger V, Knapp E, Dunn JK, et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 1992; 12:1336-45.
10. Clifton PM. Postprandial lipoproteins and coronary heart disease. J Cardiovasc Risk 1994; 1:197-201.
11. Karpe F. Postprandial lipoprotein metabolism and atherosclerosis. J Int Med 1999; 246:341-55.
12. Berglund L. Postprandial'lipemia and obesity - any unique features? Am J Clin Nutr 2002; 76:299-300.
13. Kolovou GD, Daskalova DC, Iraklianou SA, Adamopolou EN, Pilatis ND, Hatzigeorgiou GC, et al. Postprandial lipemia in hypertension. J Am Coll Nutr 2003; 22:80-7.
14. Ginsberg HN, Illingworth DR. Postprandial dyslipidemia: An atherogenic disorder common in patients with diabetes mellitus. Am J Cardiol 2001; 88:9H-15H.
15. Schrezenmeir J, Fenselau S, Kepplet I, Abel J, Orth B, Laue C, et al Postprandial triglyceride high response and the metabolic syndrome. Am N Y Acad Sci 1997; 827:353-68.
16. Kolovou G, Anagnostopoulou K, Cokkinos DV. Pathophysiology of dyslipidemia in the metabolic syndrome. Post Med J 2005; 81 358-66.
17. Alberti KG, Zimmet P, Shaw J, for the IDF Epidemiology task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005; 366:1059-62.
18. Seftel HC. The rarity of coronary artery disease in South African blacks. S Afr Med J 1978; 54:99-105.
19. Akinboboye O, Idris O, Akinboboye O, Akinkugbe O. Trends in coronary artery disease and associated risk factors in sub-Saharan Africans. J Hum Hypertens 2003; 17:381-87.
20. Hakim JG, Odwee MG, Siziya S, Temouth I, Matenga J. Acute myocardial infarction in Zimbabwe: The changing scene of coronary artery disease. Cent Afr J Med 1995; 41:303-08.
21. Opie LH, Mayosi BM. Cardiovascular disease in sub-Saharan Africa. Circulation 2005; 112:3536-40.
22. Steyn K, Sliwa K, Hawken S, Commerford P, Onen C, Damasceno A, et al for the INTERHEART Investigators in Africa. Risk factors associated with myocardial infarction in Africa: The INTERHEART Africa study. Circulation 2005; 112:3554-61.
23. Oosthuizen W, Vorster HH, Kruger A, Venter CS, Kruger HS. Impact of urbanisation on serum lipid profiles - the THUSA survey. S Afr Med J 2002; 92:723-28.
24. Norman R, Bradshaw D, Steyn K, Gaziano T, and the South African Comparative Risk Assessment Collaborating Group.Estimating the burden of disease attributable to high cholesterol in South Africa in 2000. S Afr J Med 2007; 97:708-15.
25. Patsth JR, Karlin JB, Scott LW, Smith LC, Gotto AM Jr. Inverse relationship between blood levels of high density lipoprotein sub fraction 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci USA 1983; 80:1449-53.
26. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
27. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Br Med J 1990; 300:230-35.
28. Couillard C, Bergeron N, Prud'homme D, Bergeron J, Tremblay A, Bouchard C, et al. Postprandial triglyceride response in visceral obesity in men. Diabetes 1998; 47:953-60.
29. Mekki N, Christofilis MA, Charbonnier M, Atlan-Gener C, Defoort C, Juhel C, et al. Influence of obesity and body fat distribution on postprandial lipaemia and triglyceride-rich lipoproteins in adult women. J Clin Endocrinol Metab 1999; 84:184-91.
30. Kolovou GD, Anagnostopoulou K, Pavlidis AN, Salpea KD, Hoursalis IS, Manolis A, et al. Postprandial lipaemia in menopausal women with metabolic syndrome. Maturitas 2006; 55:19-26.
31. Kolovou GD, Anagnostopoulou KK, Pavlidis AN, Salpea KD, Iraklianou SA, Tsarpalis K, et al. Postprandial lipaemia in men with metabolic syndrome, hypertensives and healthy subjects. Lipids Health Dis 2005; 4:21.
32. Kolovou GD, Anagnostopoulou KK, Pavlidis AN, Salpea KD, Iraklianou SA, Hoursalis IS, et al. Metabolic syndrome, and gender differences in postprandial lipaemia. Eur J Cardiovasc Prev Rehab 2006; 4 661-64.
33. Schaefer EJ, Audelin MC, McNamara JR, Shah PK, Tayler T, Daly JA, et al. Comparison of fasting and postprandial plasma lipoproteins in subjects with and without coronary heart disease. Am J Cardiol 2001; 88:1129-33.
34. Karpe F, Tornwall P, Olivecrona T, Steiner G, Carlson LA, Hamsten A. Composition of human low density lipoprotein: Effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein. Atherosclerosis 1993; 98 33-49.
35. Krauss R. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk. Curr Opin Lipidol 1991; 5:339-49.
36. Lamarche B, Lemieux, Després J-P. The small, dense LDL phenotype and risk of coronary heart disease: Epidemiology, pathophysiology, and therapeutic aspects. Diabetes Metab 1999; 25:199-211.
37. Austin MA. Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype. Curr Atheroscler Rep 2000; 2 200-7.
38. Griffin B. Lipoprotein atherogenicity: An overview of current mechanisms. Proc Nutr Soc 1999; 58:163-9.
39. Rizzo M, Barbagallo CM, Severino M, Polizzi P, Onorato F, Noto D, et al., Low-density-lipoprotein peak particle size in a Mediterranean population. Eur J Clin Invest 2003; 33:126-33.
40. Cho HK, Shin G, Ryu SK, Jang Y. Dav SP, Stewart G, et al. Regulation of small, dense LDL concentration in Korean and Scottish men and women. Atherosclerosis 2002; 164:187-93.
41. Kral BG, Becker LC, Yook RM, Blumenthal - RS, Kwiterovich PO, Jr, Otvos JD, et al. Racial differences in low-density lipoprotein particle size in families at high risk for premature coronary heart disease. Ethn Dis 2001; 11:325-37.
42. Miljkovic-Gacic I, Bunker CH, Ferrell RE, Kammerer CM, Evans RW, Patrick AL, Kuller LH. Lipoprotein subclass and particle size differences in Afro-Caribbeans, African Americans, and white Americans: Associations with hepatic lipase gene variation. Metabolism 2006; 55 96-102.
43. Karpe F, Steiner G, Uffelman K, Olivecrona. T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994; 106:83-97.
44. Uiterwaal CS, Grobbee DE, Witteman JC, van Stiphout WA, Krauss XH, Havekes LM, et al. Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis. Ann Intern Med 1994; 121:614-15.
45. Eliasson B, Mero N, Taskinen MR, Smith U. The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis 1997; 129:79-88.
46. Cabezas MC, De Bruin TW, Westerveld, HE, Meijer E, Erkelas DW. Delayed chylomicrons remnant clearance in subjects with heterozygous familial hypercholesterolemia. J Intern Med 1998; 244:299-307.
47. McBride PE. Triglycerides and risk for coronary heart disease JAMA 2007; 298:336-38.